MedPage Today  Aug 17  Comment 
(MedPage Today) -- Methotrexate dosing in dual therapy can be tailored to patient's response
FiercePharma  Aug 4  Comment 
The FDA has given the go-ahead for a small Pennsylvania company to launch the first drug made using three-dimensional printing. Aprecia Pharmaceuticals says on Monday the FDA approved Spritam, a formulation of epilepsy drug levetiracetam that uses...
Benzinga  Aug 3  Comment 
Aprecia Pharmaceuticals Company today announced that the U.S. Food and Drug Administration (FDA) has approved SPRITAM® levetiracetam for oral use as a prescription adjunctive therapy in the treatment of partial onset seizures, myoclonic...
The Economic Times  Jul 31  Comment 
The FTSEurofirst 300 index of top European shares was flat at 1,570.90 points by 0709 GMT.
Benzinga  Jul 29  Comment 
In a report published Wednesday, Jefferies analyst Chris Howerton downgraded the rating on Immunomedics, Inc. (NASDAQ: IMMU) from Buy to Hold, while reducing the price target from $6 to $2, after the company's partner reported disappointing...
FierceBiotech  Jul 28  Comment 
UCB says that its two Phase III trials for their lupus drug epratuzumab failed. The developer said that neither of the two doses used in the identical, late-stage trials proved statistically superior to a placebo.
MedPage Today  Jul 9  Comment 
(MedPage Today) -- Less joint damage seen with certolizumab-methotrexate combo
Forbes  Jun 26  Comment 
Judd Apatow discussed his new book, Sick in the Head: Conversations About Life and Comedy ?a collection of interviews with comedians and others, some done as a teenager?and his stand-up career in a conversation last week with NPR host Ira Glass...
The Hindu Business Line  Jun 19  Comment 
Dr Reddy’s Laboratories today said it has completed the acquisition of select portfolio of established brands of Belgian firm UCB in India.“...with regard to acquisition of select portfolio...

You may also be interested in articles related to UCB SA (UCB-BT):
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki